These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3791835)

  • 1. Intravenous drug administration to low birthweight infants.
    Giacoia GP
    Clin Pediatr (Phila); 1987 Jan; 26(1):25-9. PubMed ID: 3791835
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation of intelligent infusion technology in a multihospital setting.
    Dusing Wiest M; Longshore L; Harger N
    Am J Health Syst Pharm; 2010 Jun; 67(11):878-83. PubMed ID: 20484209
    [No Abstract]   [Full Text] [Related]  

  • 3. User satisfaction with an intravenous medication safety system.
    Eckel SF; Anderson P; Zimmerman C; Szandzik EG; McAllister JC
    Am J Health Syst Pharm; 2006 Aug; 63(15):1419-23. PubMed ID: 16849706
    [No Abstract]   [Full Text] [Related]  

  • 4. Administration guidelines for parenteral drug therapy. Part I: Pediatric patients.
    Klaus JR; Knodel LC; Kavanagh RE
    J Pharm Technol; 1989; 5(3):101-28. PubMed ID: 10318297
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems in administration techniques and dose measurement that influence accuracy of i.v. drug delivery.
    Reilly KM
    Am J Hosp Pharm; 1987 Nov; 44(11):2545-50. PubMed ID: 3318419
    [No Abstract]   [Full Text] [Related]  

  • 6. [The interaction of drugs in simultaneous administration in pediatric practice].
    Preferanskaia NG
    Med Sestra; 1989 Jan; 48(1):35-8. PubMed ID: 2927292
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of the extremely low birthweight infant.
    Shennan AT
    Clin Invest Med; 1985; 8(4):352-4. PubMed ID: 4075621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical guide for drug administration by intravenous infusion in intensive care units.
    Trujillo MH; Arai K; Bellorin-Font E
    Crit Care Med; 1994 Jun; 22(6):1049-63. PubMed ID: 8205815
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous infusion of medications in very low birth weight infants.
    Vanhole C; Jannes F; Vrancken M; Naulaers G; Allegaert K; Willems L; Devlieger H
    Eur J Clin Pharmacol; 2004 Jul; 60(5):383-6. PubMed ID: 15168102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting drug delivery by retrograde infusion.
    Berro MS; Edwards DL; Khalidi N; Sanders CA
    Am J Hosp Pharm; 1987 Jun; 44(6):1412-3. PubMed ID: 3618623
    [No Abstract]   [Full Text] [Related]  

  • 11. The drug disc. Warning system for drug interactions.
    Whiting B; Goldberg A; Waldie P
    Lancet; 1973 May; 1(7811):1037-8. PubMed ID: 4122115
    [No Abstract]   [Full Text] [Related]  

  • 12. Ad hoc versus standardized admixtures for continuous infusion drugs in neonatal intensive care: cognitive task analysis of safety at the bedside.
    Brannon TS
    AMIA Annu Symp Proc; 2006; 2006():862. PubMed ID: 17238482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems presented by components of drug vehicles.
    Rogers ML; Barrett CW
    J Hum Nutr; 1976 Feb; 30(1):41-5. PubMed ID: 1026771
    [No Abstract]   [Full Text] [Related]  

  • 14. Blocking i.v. drug incompatibilities.
    Trissel LA
    Nursing; 1993 Jun; 23(6):74. PubMed ID: 8510845
    [No Abstract]   [Full Text] [Related]  

  • 15. Considering product features and costs in selecting a system for intermittent i.v. drug delivery.
    Rapp RP
    Am J Hosp Pharm; 1987 Nov; 44(11):2533-8. PubMed ID: 3318417
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal drug reactions among medical inpatients.
    Shapiro S; Slone D; Lewis GP; Jick H
    JAMA; 1971 Apr; 216(3):467-72. PubMed ID: 5107928
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT
    Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract]   [Full Text] [Related]  

  • 18. Incompatibilities of additives to intravenous infusion fluids.
    Bourne D
    Aust Nurses J; 1976 Dec-1977 Jan; 6(6-7):23, 35. PubMed ID: 1053312
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs commonly administered by intravenous infusion in intensive care units: a practical guide.
    Trujillo MH; Bellorin-Font E
    Crit Care Med; 1990 Feb; 18(2):232-8. PubMed ID: 2404666
    [No Abstract]   [Full Text] [Related]  

  • 20. Features of i.v. devices and equipment that affect i.v. drug delivery.
    Leff RD
    Am J Hosp Pharm; 1987 Nov; 44(11):2530-3. PubMed ID: 3318416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.